Patents
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
04/1999
04/01/1999CA2300051A1 Amide derivatives for the treatment of diseases mediated by cytokines
04/01/1999CA2272605A1 Pharmaceutical composition containing gp34 binding-inhibitory agent as effective ingredient
04/01/1999CA2246004A1 A kringle-related clone, hthbz47
03/1999
03/31/1999EP0905248A1 Staphylococcus aureus MurE protein and nucleic acids encoding it
03/31/1999EP0905245A1 Staphylococcal polypeptides Spo0J1
03/31/1999EP0905237A2 PIGR-2 A member of immunoglobulin gene superfamily
03/31/1999EP0905234A2 Allelic variant of human STAT3
03/31/1999EP0905233A2 Staphylococcus aureus trigger factor
03/31/1999EP0905139A2 5 ring heterocyles, process for preparation, use as inhibitors of leukocyte adhesion and pharmaceutical preparations comprising them
03/31/1999EP0905126A1 Metalloproteinase inhibitors
03/31/1999EP0904774A1 Resorcinol derivatives
03/31/1999EP0904374A1 Processed polypeptides with il-16 activity, process for preparing the same and their use
03/31/1999EP0904278A1 Apoptosis inducing molecule ii
03/31/1999EP0904272A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
03/31/1999EP0904270A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents
03/31/1999EP0904269A1 3,4-diaryl-2-hydroxy-2,5-dihydrofurans as prodrugs to cox-2 inhibitors
03/31/1999EP0904260A1 Inhibition of matrix metalloproteases by 2-(omega-aroylalkyl)-4-biaryl-oxobutyric acids
03/31/1999EP0904112A1 Composition comprising interleukin-1 inhibitor and controlled release polymer
03/31/1999EP0904092A1 Purified extract of harpagophytum procumbens and/or harpagophytum zeyheri dence, process for its production and its use
03/31/1999EP0904090A1 Egg anti-inflammatory composition, method of isolation and use
03/31/1999EP0904073A1 Zwitterionic compositions and methods as biological response modifiers
03/31/1999EP0904072A1 Methods of treating immunopathologies using polyunsaturated fattyacids
03/31/1999EP0904061A1 Pharmaceutical composition with base of rhein or diacerhein with improved biological availability
03/31/1999EP0750507A4 PROTEASOME REGULATION OF NF--g(k)B ACTIVITY
03/31/1999EP0733035B1 Tricyclic derivatives, pharmaceutical compositions containing them
03/31/1999CN1212689A Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds
03/31/1999CN1212684A 4-anilinoquinazoline derivatives
03/31/1999CN1212620A Mercapto derivatives as inhibitors of cyclooxygenases
03/30/1999US5889178 N-(2,2-diphenylethyl)-derivatives
03/30/1999US5889143 Evaluation and treatment of patients with progressive immunosuppression
03/30/1999US5889057 Suckable solid
03/30/1999US5889049 Use of terpene compounds for reduced release of arachidonic acid and of inflammation mediators
03/30/1999US5889037 Prevention, therapy tissue damage from lipid peroxidation
03/30/1999US5889036 Prophylactic or therapeutic drug for renal diseases
03/30/1999US5889030 Method for stabilizing pranoprofen and stable liquid preparation of pranaprofen
03/30/1999US5889014 Heterocyclic compounds for inhibiting phosphodiesterase IV
03/30/1999US5889003 Phosphodiesterase inhibitor
03/30/1999US5888982 Regulation of vascular smooth muscle cell heme oxygenase-1
03/30/1999US5888969 Crohn*s disease
03/30/1999US5888523 Topical non-steroidal anti-inflammatory drug composition
03/30/1999CA2157927C Therapeutic uses of bactericidal/permeability increasing protein produc ts
03/30/1999CA2053903C Heterocyclic n-oxide derivatives of substituted benzo¬5,6|cycloheptapyridines, compositions and methods of use
03/30/1999CA1340472C Universal t-cell epitope derived from p. faciparum circumsporosoite protein
03/25/1999WO1999014346A2 SENSE mRNA THERAPY
03/25/1999WO1999014322A2 Allelic variant of human stat3
03/25/1999WO1999014231A2 Bifidus stimulating peptides and its uses
03/25/1999WO1999014213A1 Substituted chroman derivatives
03/25/1999WO1999014212A1 Substituted chroman derivatives
03/25/1999WO1999014207A1 Substituted indan derivatives
03/25/1999WO1999014205A1 New 2-(3h)-oxazolone derivatives
03/25/1999WO1999014197A1 Substituted isoquinolines as anticonvulsivants
03/25/1999WO1999014195A1 2-aminopyridines as inhibitors of cyclooxygenase-2
03/25/1999WO1999014194A1 2,3,5-trisubstituted pyridines as inhibitors of cyclooxygenase-2
03/25/1999WO1999013910A1 Neovascularization inhibitor
03/25/1999WO1999013885A1 Modulation of immune responses
03/25/1999WO1999013799A1 Synergistic analgesic combination of opioid analgesic and cyclooxygenase-2 inhibitor
03/25/1999WO1998051665A3 Novel macrocyclic compounds as metalloprotease inhibitors
03/25/1999WO1998050530A9 Enzymatic nucleic acids: synthesis, selection and use
03/25/1999DE19742014A1 Use of new and known tetracyclene compounds as phospholipase inhibitors
03/25/1999CA2304982A1 Sense mrna therapy
03/25/1999CA2304119A1 Modulation of immune responses
03/25/1999CA2304037A1 Substituted chroman derivatives
03/25/1999CA2303926A1 Substituted chroman derivatives
03/25/1999CA2303839A1 Substituted indan derivatives
03/25/1999CA2303777A1 Substituted isoquinolines as anticonvulsivants
03/25/1999CA2244971A1 Mure
03/25/1999CA2244954A1 Murf
03/24/1999EP0903353A1 Imidazolidine derivates, their preparation and use, and pharmaceutical compositions containing them
03/24/1999EP0903349A2 CCR-3 receptor antagonists
03/24/1999EP0903345A1 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamid
03/24/1999EP0902789A1 Androstene derivatives
03/24/1999EP0902782A1 Urea derivatives as inhibitors of impdh enzyme
03/24/1999EP0902681A1 Inhibition of selectin binding
03/24/1999EP0745063B1 Substituted biphenyl derivatives as phosphodiesterase inhibitors
03/24/1999EP0667855B1 Substituted arylalkynyl- and heteroarylalkynyl-n-hydroxyurea inhibitors of leukotriene biosynthesis
03/24/1999EP0563128B1 New 3,4-dihydroisoquinoline derivates and new pharmaceutical use of carbocyclically and heterocyclically annulated dihydropyridines
03/24/1999CN1211917A Pharmaceutical composition with base of rhein or diacerhein with improved biological availability
03/24/1999CN1211572A Cyclic amine derivatives-CCR-3 receptor antagonists
03/24/1999CN1211442A Medicated plaster for treating lumbago
03/24/1999CN1211440A Pasting preparation for eliminating pain
03/23/1999US5886178 3-aroylbenzylpyridazinone derivatives
03/23/1999US5886177 Phosphate linked oligomers
03/23/1999US5886053 Use of carotenoids for producing drugs for the treatment of dermatoses
03/23/1999US5886044 IL-8 receptor antagonists
03/23/1999US5886020 3-(4'-dimethylaminobenzylidenyl)-2-indolinone and analogues thereof for the treatment of disease
03/23/1999US5886009 Quinuclidine derivative as a substance P antagonist
03/23/1999US5885978 External therapeutic composition for dermatitis
03/23/1999US5885800 DNA encoding tumor necrosis related receptor, TR4
03/23/1999US5885795 Methods of expressing angiostatic protein
03/23/1999CA2247735A1 Novel 5-membered ring heterocycles, their preparation, their use and pharmaceutical preparations comprising them
03/23/1999CA2173457C Use of 5-alpha reductase inhibitorsand compositions for treating androg enic alopecia
03/23/1999CA2022611C Optical resolution method for 3s-(3-carboxybenzyl)-6-(5-fluoro-2-benzothiazolyl)methoxy-4s-chromanol
03/23/1999CA2016181C Arylthiazolylimidazoles as 5ht3 antagonists
03/23/1999CA2008771C Pyridinium nitrate, its production and use
03/23/1999CA1340463C Alkanophenones
03/18/1999WO1999013080A1 Beta-defensins
03/18/1999WO1999013064A2 Viral infection of cells using viral vectors
03/18/1999WO1999013055A1 Human sigma receptor
03/18/1999WO1999012944A2 SYNTHETIC DIVALENT sLex CONTAINING POLYLACTOSAMINES AND METHODS FOR USE
03/18/1999WO1999012934A1 Pyrrolopyrrolone derivatives